Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00187915 · ClinicalTrials.gov registry record · NA
Pilot Trial for Implementation of a MPA PK Monitoring Strategy
A NA study of Transplant, Kidney, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT00187915 is a NA study of Transplant, Kidney that has completed, run by University of Florida. The registered enrollment target is 24 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00187915, a NA study of Transplant, Kidney, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a prospective interventional trial of de novo renal transplant recipients, aiming to validate a strategy which combines the use of early post transplant MPA AUC sampling, and subsequent MPA trough level monitoring to implement MPA PK monitoring in a clinically applicable fashion.
Conditions Studied
Interventions
- DRUG Mycophenolate mofetil + Tacrolimus
- DRUG Mycophenolate mofetil + Cyclosporin
Study Locations (1)
Florida
- University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2003-07 |
| Est. Completion | 2004-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00187915
The ClinicalTrials.gov registry entry for NCT00187915 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Transplant, Kidney appearing as the primary indexed condition, and to 2 interventions - of which Mycophenolate mofetil + Tacrolimus is the first listed.
NCT00187915 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT00187915 about?
NCT00187915 is a clinical study titled "Pilot Trial for Implementation of a MPA PK Monitoring Strategy". This study is a prospective interventional trial of de novo renal transplant recipients, aiming to validate a strategy which combines the use of early post transplant MPA AUC sampling, and subsequent MPA trough level monitoring to implement MPA PK monitoring in a clinically applicable fashion.
What is the current status of trial NCT00187915?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2003-07. Estimated completion is 2004-12.
What conditions does trial NCT00187915 study?
This clinical trial studies the following conditions: Transplant, Kidney.
What interventions are being tested in trial NCT00187915?
The interventions under investigation include: Mycophenolate mofetil + Tacrolimus (DRUG), Mycophenolate mofetil + Cyclosporin (DRUG).
Who is sponsoring clinical trial NCT00187915?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00187915 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.